Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06636760
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-09-26
Brief Title:
Efficacy and Immunomodulator Impact of Herbal Combination on COVID-19 Patients Recovery
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Efficacy and Safety of Herbal Combination As Adjuvant Therapy for Mild and Moderate COVID-19 Patients
Status:
COMPLETED
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to evaluate the efficacy and safety of Herbamuno a combination of several herbal ingredients as an adjunct therapy for moderate COVID-19 patients at Wisma Atlet The study involves 66 patients who were divided into two groups one receiving Herbamuno and the other a placebo both for 14 days Researchers monitored clinical improvements chest X-rays and blood tests to assess inflammation and immune response The goal is to determine whether Herbamuno can be safely and effectively added to standard COVID-19 treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None